FDA plans ahead for COVID-19 mutations with booster shot guidance

FDA issued new guidance for vaccine makers as it is preparing for the possibility of needing to approve COVID-19 booster shots against variants of the SARS-CoV-2 virus which cause COVID-19.

Source:

Biospace Inc.